The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study
Background: Older people with Intellectual Disability (ID) have a high prevalence of gastrointestinal conditions such as Gastro-Oesophageal Reflux Disease (GORD). However, despite this, information about treatment, in particular the use of Proton Pump Inhibitors (PPIs), in this population is sparse...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-11-01
|
| Series: | Saudi Pharmaceutical Journal |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016418301105 |
| _version_ | 1818555405864796160 |
|---|---|
| author | Hadiah AlMutairi Máire O'Dwyer Mary McCarron Philip McCallion Martin C. Henman |
| author_facet | Hadiah AlMutairi Máire O'Dwyer Mary McCarron Philip McCallion Martin C. Henman |
| author_sort | Hadiah AlMutairi |
| collection | DOAJ |
| description | Background: Older people with Intellectual Disability (ID) have a high prevalence of gastrointestinal conditions such as Gastro-Oesophageal Reflux Disease (GORD). However, despite this, information about treatment, in particular the use of Proton Pump Inhibitors (PPIs), in this population is sparse and limited. Objective: To investigate the prevalence and pattern of PPI use among older people with ID. Method: Data on PPI use and key demographics was analysed from Wave 2 (2013/2014) of IDS-TILDA, a nationally representative longitudinal study of 677 participants aged 40 years and above in Ireland. Descriptive statistics, bivariate analyses and binary logistic regression were carried out. Results: Just over a quarter, 27.9% (n = 189), of participants reported use of PPIs, and 53.4% (n = 101) were female. The largest proportion of PPI users (53.4%) were aged between 50 and 64 yrs. Most of the PPIs were used in maximum doses (66.7%). However only 43.9% of PPI users had an indication for PPI use (GORD, stomach ulcer or/and an NSAID use), and further 13.2% were also taking an antiplatelet agent. Use among those in residential care homes (54.3%) was much higher than for those living independently or with family (7%). PPI use among those who have severe/profound ID was 25% higher than those with mild ID. Information about the length of PPI use was missing for 31.2%, but of those with data, just over half recorded using the PPIs for more than a year. Apart from an indication, the factors associated with PPI use were older ages (≥50 years), severe/profound level of ID. Conclusion: PPI use among older people with intellectual disability is prevalent and frequently long term, often without a clear indication. PPI use especially among those with severe/profound ID and those who live in residential care homes, could predispose these individuals to additional comorbidities and in order to avoid inappropriate long term of use regular review is required. Keywords: Older people, Intellectual disability, Proton pump inhibitors, Medicine use, Inappropriate, Polypharmacy |
| first_indexed | 2024-12-12T09:53:02Z |
| format | Article |
| id | doaj.art-7104534ece9b4d8398c7a31ae22af635 |
| institution | Directory Open Access Journal |
| issn | 1319-0164 |
| language | English |
| last_indexed | 2024-12-12T09:53:02Z |
| publishDate | 2018-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Saudi Pharmaceutical Journal |
| spelling | doaj.art-7104534ece9b4d8398c7a31ae22af6352022-12-22T00:28:13ZengElsevierSaudi Pharmaceutical Journal1319-01642018-11-0126710121021The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational studyHadiah AlMutairi0Máire O'Dwyer1Mary McCarron2Philip McCallion3Martin C. Henman4School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland; Corresponding author at: IDS-TILDA, School of Nursing & Midwifery, Trinity College Dublin, Dublin, Ireland.School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, IrelandFaculty of Health Sciences, Trinity College Dublin, Dublin, IrelandSchool of Social Work, Temple University, Philadelphia, PA, USASchool of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, IrelandBackground: Older people with Intellectual Disability (ID) have a high prevalence of gastrointestinal conditions such as Gastro-Oesophageal Reflux Disease (GORD). However, despite this, information about treatment, in particular the use of Proton Pump Inhibitors (PPIs), in this population is sparse and limited. Objective: To investigate the prevalence and pattern of PPI use among older people with ID. Method: Data on PPI use and key demographics was analysed from Wave 2 (2013/2014) of IDS-TILDA, a nationally representative longitudinal study of 677 participants aged 40 years and above in Ireland. Descriptive statistics, bivariate analyses and binary logistic regression were carried out. Results: Just over a quarter, 27.9% (n = 189), of participants reported use of PPIs, and 53.4% (n = 101) were female. The largest proportion of PPI users (53.4%) were aged between 50 and 64 yrs. Most of the PPIs were used in maximum doses (66.7%). However only 43.9% of PPI users had an indication for PPI use (GORD, stomach ulcer or/and an NSAID use), and further 13.2% were also taking an antiplatelet agent. Use among those in residential care homes (54.3%) was much higher than for those living independently or with family (7%). PPI use among those who have severe/profound ID was 25% higher than those with mild ID. Information about the length of PPI use was missing for 31.2%, but of those with data, just over half recorded using the PPIs for more than a year. Apart from an indication, the factors associated with PPI use were older ages (≥50 years), severe/profound level of ID. Conclusion: PPI use among older people with intellectual disability is prevalent and frequently long term, often without a clear indication. PPI use especially among those with severe/profound ID and those who live in residential care homes, could predispose these individuals to additional comorbidities and in order to avoid inappropriate long term of use regular review is required. Keywords: Older people, Intellectual disability, Proton pump inhibitors, Medicine use, Inappropriate, Polypharmacyhttp://www.sciencedirect.com/science/article/pii/S1319016418301105 |
| spellingShingle | Hadiah AlMutairi Máire O'Dwyer Mary McCarron Philip McCallion Martin C. Henman The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study Saudi Pharmaceutical Journal |
| title | The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study |
| title_full | The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study |
| title_fullStr | The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study |
| title_full_unstemmed | The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study |
| title_short | The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study |
| title_sort | use of proton pump inhibitors among older adults with intellectual disability a cross sectional observational study |
| url | http://www.sciencedirect.com/science/article/pii/S1319016418301105 |
| work_keys_str_mv | AT hadiahalmutairi theuseofprotonpumpinhibitorsamongolderadultswithintellectualdisabilityacrosssectionalobservationalstudy AT maireodwyer theuseofprotonpumpinhibitorsamongolderadultswithintellectualdisabilityacrosssectionalobservationalstudy AT marymccarron theuseofprotonpumpinhibitorsamongolderadultswithintellectualdisabilityacrosssectionalobservationalstudy AT philipmccallion theuseofprotonpumpinhibitorsamongolderadultswithintellectualdisabilityacrosssectionalobservationalstudy AT martinchenman theuseofprotonpumpinhibitorsamongolderadultswithintellectualdisabilityacrosssectionalobservationalstudy AT hadiahalmutairi useofprotonpumpinhibitorsamongolderadultswithintellectualdisabilityacrosssectionalobservationalstudy AT maireodwyer useofprotonpumpinhibitorsamongolderadultswithintellectualdisabilityacrosssectionalobservationalstudy AT marymccarron useofprotonpumpinhibitorsamongolderadultswithintellectualdisabilityacrosssectionalobservationalstudy AT philipmccallion useofprotonpumpinhibitorsamongolderadultswithintellectualdisabilityacrosssectionalobservationalstudy AT martinchenman useofprotonpumpinhibitorsamongolderadultswithintellectualdisabilityacrosssectionalobservationalstudy |